Skip to content

Clinical trials

Phase 3 Breast Neoplasms trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Phase: Phase 3 Country / region: Italy Clear all

216 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20015
20023
200311
20048
20057
200610
200710
20086
200911
20105
20117
20126
20139
20148
20158
20163
20174
20188
20197
20204
202116
202210
202313
20245
202512
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed115
Active, not recruiting43
Recruiting25
Terminated17
Unknown status15
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche37
AstraZeneca23
Novartis Pharmaceuticals22
Pfizer13
Eli Lilly and Company10
ETOP IBCSG Partners Foundation9
Sanofi5
Daiichi Sankyo4
European Organisation for Research and Treatment of Cancer - EORTC4
GlaxoSmithKline4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms216
Neoplasm Metastasis29
Neoplasms13
Breast Diseases6
Neoplasms by Site5
Recurrence4
Triple Negative Breast Neoplasms4
Brain Neoplasms3
Carcinoma, Intraductal, Noninfiltrating2
Cardiotoxicity2

Trials

Showing 1 to 25 of 216. Each trial links to its page on Pharma Observatory.

116 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.